|
|
Gastric and Esophageal Malignancies in Northern Iran (GEMINI): Case-Control Study
|
ZIA CP000185-10318
|
$44,211
|
$44,211
|
Abnet, Christian
|
DCEG (NCI)
|
|
|
The Golestan Cohort Study
|
ZIA CP000185-10361
|
$27,523
|
$27,523
|
Abnet, Christian
|
DCEG (NCI)
|
|
|
Role of TLR4 in colitis-associated neoplasia
|
5R01CA137869-05
|
$289,474
|
$289,474
|
Abreu, Maria
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
|
Improving Risk Stratification for Colonoscopy Screening
|
1R03CA171836-01A1
|
$75,000
|
$75,000
|
Adams, Kenneth
|
HEALTHPARTNERS INSTITUTE
|
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-11
|
$24,894,951
|
$248,950
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)
|
5U54CA163069-03
|
$1,113,511
|
$22,270
|
Adunyah, Samuel
|
MEHARRY MEDICAL COLLEGE
|
|
|
Mesothelin as a biomarker for clinical management of esophageal adenocarcinoma
|
5R21CA164585-02
|
$186,970
|
$186,970
|
Adusumilli, Prasad
|
SLOAN-KETTERING INST CAN RES
|
|
|
Colon Cancer Chemoprevention by Flavonoid Silibinin
|
5R01CA112304-08
|
$269,324
|
$269,324
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
|
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis
|
1R01CA180149-01
|
$590,138
|
$590,138
|
AGUS, DAVID
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
APC Tumor Suppressor in Cell Differentiation and Death
|
5R01CA105038-08
|
$246,543
|
$246,543
|
Ahmed, Yasmath
|
DARTMOUTH COLLEGE
|
|
|
Gut Microbiome Profiles and Risk of Colorectal Cancer
|
5R03CA159414-02
|
$79,430
|
$79,430
|
Ahn, Jiyoung
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-10
|
$13,680
|
$547
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
Participation in the Eastern Cooperative Oncology Group
|
7U10CA107868-11
|
$160,010
|
$6,400
|
AISNER, JOSEPH
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
|
Inhibition of Hedgehog Signaling in Gli-1+Adeno CA of the Esoph or GE junction
|
1R01CA172741-01A1
|
$279,793
|
$279,793
|
Ajani, Jaffer
|
UT MD ANDERSON CANCER CTR
|
|
|
Prediction of Pathologic Complete Response by Gene Expression Profiling in Esopha
|
5R01CA138671-04
|
$291,367
|
$291,367
|
Ajani, Jaffer
|
UT MD ANDERSON CANCER CTR
|
|
|
Complications of Jaw Osteoradionecrosis in Cancer Management
|
5K22CA169089-02
|
$196,344
|
$196,344
|
AKINTOYE, SUNDAY
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,207,080
|
$60,354
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
|
Southeast Michigan Community Network Program
|
5U54CA153606-04
|
$705,220
|
$112,835
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
|
Multiplexed Measurement of Kinase Activity in Single Cancer Cells
|
5R01CA139599-05
|
$505,646
|
$252,823
|
Allbritton, Nancy
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
|
Novel Hedgehog Receptors As Therapeutic Targets In Pancreatic Cancer
|
5R21CA167122-02
|
$127,168
|
$127,168
|
Allen, Benjamin
|
UNIVERSITY OF MICHIGAN
|
|
|
Cancer Margin Detection using Infrared Spectroscopy and Plasmon Resonance
|
5R21CA167403-02
|
$151,050
|
$51,357
|
Allen, Heather
|
OHIO STATE UNIVERSITY
|
|
|
The effects of endogenous and dietary estrogens on colonic stem cells
|
5R21CA164623-02
|
$175,438
|
$175,438
|
Allred, Clinton
|
TEXAS AGRILIFE RESEARCH
|
|
|
Creating a 3D dynamic in vitro model of the tumor microenvironment to characteriz
|
5F31CA163049-03
|
$36,306
|
$36,306
|
Alonzo, Luis
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
|
Rational Design and Clinical Development of Shepherdin: A Novel Anti-Cancer Agent
|
5R01CA118005-06
|
$325,422
|
$107,389
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
|
HLTF gene silencing: a novel determinant of sensitivity to autophagy inhibition
|
1R01CA169134-01A1
|
$423,754
|
$423,754
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Genome-Wide Predictors of Treatment-Related Toxicities
|
5R01CA139426-03
|
$927,470
|
$324,615
|
Ambrosone, Christine
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$708,251
|
$177,063
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
Dietary Prevention of Cancer
|
5R01CA109269-10
|
$264,653
|
$264,653
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
|
RNA Binding Proteins in Cancer
|
5R01CA135559-05
|
$283,799
|
$283,799
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
|
Role of Id1 in adiposity, energy balance and obesity associated liver tumorigenes
|
1K22CA168828-01
|
$146,259
|
$146,259
|
Ande, Satyanarayana
|
GEORGIA REGENTS UNIVERSITY
|
|
|
Women's Health Initiative Cancer Survivor Cohort
|
1UM1CA173642-01
|
$1,894,768
|
$341,058
|
ANDERSON, GARNET
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Mutation-Specific p53 Antibodies as Biomarkers of Pancreatic Cancer
|
5R21CA164593-02
|
$155,627
|
$155,627
|
Anderson, Karen
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Tissue-specific Roles of Axin in Canonical Wnt Signaling and Tumorigenesis
|
5R21CA166853-02
|
$186,970
|
$186,970
|
ANDERSON, KATHRYN
|
SLOAN-KETTERING INST CAN RES
|
|
|
The University of Kentucky Cancer Nanotechnology Training Center (UK CNTC)
|
5R25CA153954-04
|
$317,669
|
$127,068
|
Anderson, Bradley
|
UNIVERSITY OF KENTUCKY
|
|
|
Children's Oncology Group Statistics and Data Center Grant
|
5U10CA098413-11
|
$5,797,460
|
$57,975
|
ANDERSON, JAMES
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
Functions of Papillomavirus E6
|
5R01CA107394-10
|
$281,939
|
$188,899
|
ANDROPHY, ELLIOT
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
|
Role of Osteoactivin in Invasion by Oral Cancers
|
1R21CA167126-01A1
|
$202,275
|
$202,275
|
AROSARENA, ONEIDA
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
|
T Cell Alternative p38 Activation Pathway
|
ZIA BC 010774
|
$263,161
|
$131,581
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-27
|
$1,874,946
|
$281,242
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
|
Targeting of Aberrant Signaling in Patient-Derived Colorectal Cancer Models
|
1K08CA175153-01
|
$173,340
|
$173,340
|
Atreya, Chloe
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
|
Mouse Models to Dissect p53 Tumor Suppressor Function
|
5R01CA140875-03
|
$322,984
|
$322,984
|
ATTARDI, LAURA
|
STANFORD UNIVERSITY
|
|
|
Elucidating p53 transcriptional networks involved in pancreatic cancer suppressio
|
5R21CA169673-02
|
$194,763
|
$194,763
|
ATTARDI, LAURA
|
STANFORD UNIVERSITY
|
|
|
MODULATION OF INTESTINAL HOMEOSTASIS AND CANCER
|
5R01CA135561-05
|
$289,457
|
$289,457
|
AUGENLICHT, LEONARD
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
|
|
Dietary Risk for Colon Cancer in the Mouse
|
5R01CA151494-03
|
$266,782
|
$266,782
|
AUGENLICHT, LEONARD
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
|
|
Eastern Cooperative Oncology Group Studies
|
3U10CA014548-38S1
|
$334,918
|
$13,397
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Decoding the MST1 and MST2 kinases in cellular physiology and tumor suppression
|
5R01CA136567-04
|
$574,756
|
$574,756
|
AVRUCH, JOSEPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Linking State Registry and All Payer Claims Data to Study Cancer Care
|
1R21CA172892-01
|
$276,331
|
$69,083
|
AYANIAN, JOHN
|
UNIVERSITY OF MICHIGAN
|
|
|
Targeting RAS signaling with CDK and AKT inhibition in pancreatic cancer
|
1R21CA172997-01A1
|
$211,410
|
$211,410
|
Azad, Nilofer
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Using FAP to Selectively Target Epithelial Cancers
|
5R01CA163930-02
|
$334,999
|
$167,500
|
BACHOVCHIN, WILLIAM
|
TUFTS UNIVERSITY BOSTON
|
|
|
Spectroscopy of blood supply changes in early precancer
|
5R01CA109861-08
|
$214,564
|
$214,564
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
Total relevant funding to Digestive Diseases for this search: $431,405,040
|
